Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran)
First publication date 4 August 2021, first update 15 April 2022, second update 7 July 2022, last update 3 October 2022
3 October 2022
| COVID-19: Vaccines
Overview
This training provides information on characteristics of different formulations of Pfizer-BioNTech COVID-19 vaccine, storage and transport requirements, procedures for effective management during storage, transport and use. It also includes guidance for establishing an ultra-cold chain system. It is recommended to select the appropriate slides/modules based on the training needs and profile of the participants.
The training slide set is organized in 8 modules:
- Module 1: Vaccine presentation, storage requirement and shelf life
- Module 2: Operational considerations on vaccine management and administration
- Module 3: Shipping and arrival procedures, and handling of manufacturer-supplied thermal shipping container
- Module 4: Recommended cold chain equipment and vaccine deployment strategies
- Module 5: Selection of UCC equipment and temperature monitoring device (TMD) for UCC hub
- Module 6: UCC system readiness
- Module 7: Vaccine transport and storage options at lower stores and service points
- Module 7.1: Transporting ULT frozen vaccine to subnational stores and service points
- Module 7.2: Equipment options for transporting and storing vaccine at lower distribution points
- Module 8: Managing vaccine storage and transport at service points
This material has been updated in English: version 3 October 2022.
WHO Team
COVAX
Number of pages
139
Copyright
CC BY-NC-SA 3.0 IGO